Netanyahu taps Mossad s deputy chief as intelligence agency s next head
Veteran spy will assume head position in June 2021 after being vetted by Goldberg Committee, stepping in for mentor Yossi Cohen; PM snubs DM Gantz on appointment
Itamar Eichner |
Published: 12.15.20 , 18:36
Prime Minister Benjamin Netanyahu has announced on Tuesday he has decided to appoint Mossad s Deputy Director D. as the next chief of the clandestine intelligence agency.
The veteran spy will assume the head position in June 2021, pending the approval of the Goldberg Committee which vets candidates for top government posts, primarily in the field of security.
3 צפייה בגלריה
(Photo: GPO)
D. is considered a protégé of current Mossad chief Yossi Cohen and has spent his entire military career in the intelligence agency as part of the army’s General Staff Reconnaissance Unit.
0 shares
The daughter of a 74-year-old Austrian citizen imprisoned in Iran has told of her fears for her father’s health after he started displaying coronavirus symptoms.
“He started suffering from fever last Thursday, but he doesn’t get the medical attention he needs, and he was denied a COVID test,” Fanak Mani, daughter of Massud Mossaheb, tells AFP of her father’s treatment in Tehran’s notorious Evin prison.
Mossaheb was detained while traveling in Iran with a delegation from an Austrian research center in January 2019 and in August it was announced that he had been jailed for 10 years on charges of spying for Israel and Germany.
1 shares
Outgoing Acting Israel Police Commissioner Motti Cohen announces that he will quit the organization following the nomination of Yaakov Shabtai as permanent police chief, and accuses decision-makers of “ulterior motives” in the failure to appoint his replacement until now.
Cohen, who has served in his interim position for two years during an extended political crisis, makes the announcement in a letter sent to fellow officers and commanders.
He also writes that he has lately faced “attempts to intervene in the work of the Israel Police, intervention that has no place in the organization and which I didn’t allow.”
0 shares
The US Food and Drug Administration (FDA) issues a positively worded briefing document about the Moderna COVID-19 vaccine ahead of a meeting by experts on whether to grant it emergency approval.
The FDA is upbeat on the vaccine, saying there are “no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorization)” and confirms an overall efficacy of 94.1 percent. AFP I m proud to work at The Times of Israel
I’ll tell you the truth: Life here in Israel isn’t always easy. But it s full of beauty and meaning.
I m proud to work at The Times of Israel alongside colleagues who pour their hearts into their work day in, day out, to capture the complexity of this extraordinary place.
0 shares
The US Food and Drug Administration authorizes the country’s first rapid at-home test for COVID-19, which is available over-the-counter and produces a result in around 20 minutes.
The test, made by California-based Ellume, will sell for around $30 and the company plans to roll out three million units in January 2021. AFP I m proud to work at The Times of Israel
I’ll tell you the truth: Life here in Israel isn’t always easy. But it s full of beauty and meaning.
I m proud to work at The Times of Israel alongside colleagues who pour their hearts into their work day in, day out, to capture the complexity of this extraordinary place.